This editorial examines how war and armed conflict profoundly disrupt cancer care systems, with particular attention to radiation therapy. Drawing on intercontinental narratives from clinicians and medical physicists, the authors argue that maintaining radiotherapy services in conflict settings presents unique operational, ethical, and policy challenges that demand sustained, collaborative solutions.
Clinicians and medical physicists who contributed experiences from Sudan, Yemen, Syria, Palestine, and Ukraine describe frontline realities of delivering radiotherapy amid instability. These narratives document service interruption from infrastructure damage, population displacement, and collapse of supply and maintenance chains. The editorial synthesizes these accounts to highlight consistent themes across different conflict contexts rather than to provide exhaustive country-by-country case reports.
Radiation therapy services are particularly susceptible to disruption because they depend on:
The combination of capital-intensive technology and human resource requirements creates fragility when conflict threatens infrastructure, supply routes, and personnel safety.
Reported operational challenges include damage to or loss of treatment facilities, interruptions to utilities, inability to perform routine quality assurance, limited access to spare parts and consumables, and disrupted referral networks. Workforce challenges include displacement of staff, interrupted training pathways, loss of local expertise, and difficulties in retaining or redeploying personnel. These issues compromise the ability to deliver safe, timely, and guideline-concordant radiotherapy.
The authors frame cancer care delivery in conflict settings as a central patient-safety and equity concern. Rather than treating oncology services as peripheral to humanitarian response, the editorial positions continued cancer care—particularly radiotherapy—as essential to protecting patient outcomes and upholding professional responsibilities. The piece stresses that prioritizing oncologic services in conflict zones is a matter of both ethical obligation and health-system resilience.
Education and workforce development are highlighted as critical priorities. The editorial calls for sustained investments in training, remote and in-person educational support, and programs to preserve local expertise despite displacement. Strengthening training pipelines and creating mechanisms to support displaced or isolated practitioners are emphasized as means to maintain a functioning clinical and physics workforce during and after conflict.
Technology and logistics comprise another priority area. Practical support includes reliable technology maintenance, access to spare parts, adaptable treatment strategies suited to resource-constrained and unstable environments, and contingency planning for utilities and physical security. The editorial underscores the importance of long-term equipment support and context-appropriate technological solutions rather than short-term, one-off donations.
The authors advocate for targeted research to document needs, test interventions, and guide policy. Advocacy is framed as a necessary complement: raising awareness among professional societies, funders, and policy makers to mobilize resources and policy attention for cancer care in conflict-affected regions. Research and advocacy together are presented as tools to shift cancer care from a marginal humanitarian issue to a prioritized global health concern.
Beyond describing problems, the editorial offers a collective call to action for the global radiation oncology community. Proposed pathways emphasize ethical grounding, long-term collaboration, and pragmatic planning. Recommended approaches include building durable partnerships, aligning education and workforce initiatives with local needs, ensuring technology and maintenance commitments, and integrating research and advocacy to sustain momentum. The editorial argues that these steps can translate heightened awareness into durable, collaborative resilience planning to protect patient safety and equitable access to radiotherapy in conflict-affected settings.
The editorial does not provide detailed implementation protocols or quantitative outcome data; instead, it synthesizes frontline observations and sets an agenda for priority interventions. The piece positions cancer care in conflict as a central contemporary challenge requiring coordinated, ethically informed action from clinicians, institutions, and global stakeholders.